Amarantus BioScience Holdings, Inc.
AMBS
$0.00
$0.000.00%
OTC PK
| 06/30/2019 | 03/31/2019 | ||||
|---|---|---|---|---|---|
| Net Income | 76.26% | 76.26% | |||
| Total Depreciation and Amortization | -- | -- | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -- | -- | |||
| Change in Net Operating Assets | 137.83% | 137.83% | |||
| Cash from Operations | -74.45% | -74.45% | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -271.64% | -271.64% | |||
| Cash from Investing | -271.64% | -271.64% | |||
| Total Debt Issued | -86.73% | -86.73% | |||
| Total Debt Repaid | 99.63% | 99.63% | |||
| Issuance of Common Stock | -98.88% | -98.88% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | 90.08% | 90.08% | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | 117.18% | 117.18% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 98.83% | 98.83% | |||